<DOC>
	<DOCNO>NCT00020345</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving drug different way , directly abdomen , combine chemotherapy radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine chemotherapy radiation therapy plus surgery treating patient advance cancer pancreas .</brief_summary>
	<brief_title>Combination Chemotherapy Radiation Therapy Plus Surgery Treating Patients With Advanced Cancer Pancreas</brief_title>
	<detailed_description>OBJECTIVES : I . Determine radiographic and/or pathologic response , time disease progression , survival patient advance adenocarcinoma pancreas treat neoadjuvant intraperitoneal gemcitabine intravenous gemcitabine radiotherapy follow surgery adjuvant intraperitoneal gemcitabine , intravenous gemcitabine , fluorouracil . II . Determine pharmacokinetics intraperitoneal gemcitabine patient . III . Correlate pattern mRNA expression response regimen prognosis patient . PROTOCOL OUTLINE : Patients receive gemcitabine intraperitoneally ( IP ) every 6 hour 4 dos day 1 . Treatment repeat 1 week total 2 course . Beginning 1-3 week completion IP chemotherapy , patient receive gemcitabine IV 30-60 minute day 1 2 week radiotherapy day 1-5 week 6 week . Within 6 week completion combination chemotherapy radiotherapy , patient stable respond disease undergo surgical resection . Patients completely resect extrapancreatic disease receive 2 additional course IP gemcitabine begin 1-3 week surgery . Beginning 3 week completion IP chemotherapy , patient receive gemcitabine IV weekly total 3 week fluorouracil IV continuously 6 month . Patients follow every 3 month 1 year , every 4 month 1 year , every 6 month 3 year . PROJECTED ACCRUAL : A total 10-100 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically cytologically confirm adenocarcinoma pancreas ampullae vater amenable curative surgery Metastases confine abdominal cavity May include peripancreatic lymph node , peritoneal carcinomatosis , hepatic metastasis Extrapancreatic disease must resectable Must progressive disease receive prior therapy No distant metastasis , include lung bone metastases Prior/Concurrent Therapy Biologic therapy : No concurrent immunotherapy pancreatic cancer Chemotherapy : No prior gemcitabine fluorouracil Endocrine therapy : No concurrent hormonal therapy pancreatic cancer Radiotherapy : No prior radiotherapy pancreatic cancer No prior abdominal pelvic radiotherapy Surgery : See Disease Characteristics Other : At least 30 day since prior anticancer therapy recover Patient Characteristics Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 2,000/mm3 Platelet count great 100,000/mm3 Hepatic : SGOT SGPT less 4 time upper limit normal No active hepatitis Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : No significant reversible ischemic change wall motion perfusion stress ( correction use angiography angioplasty allow ) No significant resting leave ventricle dysfunction No unstable angina No New York Heart Association class III IV heart disease No myocardial infarction within past 6 month Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active disease increase possibility infection , include AIDS autoimmune disorder No medical condition psychiatric disease would preclude study No concurrent malignancy except nonmelanoma skin cancer carcinoma situ cervix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>cellular diagnosis , pancreatic cancer</keyword>
	<keyword>gastrointestinal cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>stage IVA pancreatic cancer</keyword>
	<keyword>stage , pancreatic cancer</keyword>
</DOC>